OBJECTIVE: To describe characteristics of men having sex with men (MSM) participating in the Omega Cohort, to describe HIV-positive participants at baseline interview, and to estimate HIV incidence. METHODS: The Omega Cohort is a study on the incidence and psychosocial determinants of HIV infection among MSM living in Montreal. MSM complete a questionnaire and are tested for HIV every six months. RESULTS: During the previous six months, 31% and 12% of 810 participants (mean age = 33 years) reported unprotected anal sex with regular and casual partners, respectively. Eight participants (0.98%) were HIV-infected at baseline. HIV incidence was 0.89 per 100 person-years (7/787 person-years) [95% confidence interval: 0.36-1.83]. CONCLUSION: A significant proportion of participants reported current risk behaviours. Despite this, HIV incidence is relatively low. It is important to target MSM who do not practice safe sex and to encourage those practicing safe sex to sustain these behaviours.
OBJECTIVE: To describe characteristics of men having sex with men (MSM) participating in the Omega Cohort, to describe HIV-positive participants at baseline interview, and to estimate HIV incidence. METHODS: The Omega Cohort is a study on the incidence and psychosocial determinants of HIV infection among MSM living in Montreal. MSM complete a questionnaire and are tested for HIV every six months. RESULTS: During the previous six months, 31% and 12% of 810 participants (mean age = 33 years) reported unprotected anal sex with regular and casual partners, respectively. Eight participants (0.98%) were HIV-infected at baseline. HIV incidence was 0.89 per 100 person-years (7/787 person-years) [95% confidence interval: 0.36-1.83]. CONCLUSION: A significant proportion of participants reported current risk behaviours. Despite this, HIV incidence is relatively low. It is important to target MSM who do not practice safe sex and to encourage those practicing safe sex to sustain these behaviours.
Authors: S A Strathdee; R S Hogg; S L Martindale; P G Cornelisse; K J Craib; J S Montaner; M V O'Shaughnessy; M T Schechter Journal: J Acquir Immune Defic Syndr Hum Retrovirol Date: 1998-09-01
Authors: C E Stevens; P E Taylor; E A Zang; J M Morrison; E J Harley; S Rodriguez de Cordoba; C Bacino; R C Ting; A J Bodner; M G Sarngadharan Journal: JAMA Date: 1986-04-25 Impact factor: 56.272
Authors: D H Osmond; K Page; J Wiley; K Garrett; H W Sheppard; A R Moss; L Schrager; W Winkelstein Journal: Am J Public Health Date: 1994-12 Impact factor: 9.308
Authors: Thomas M Lampinen; Keith Chan; Robert S Remis; Maraki Fikre Merid; Melanie Rusch; Jean Vincelette; Ken Logue; Vladimir Popovic; Michel Alary; Martin T Schechter; Robert S Hogg Journal: CMAJ Date: 2005-02-15 Impact factor: 8.262
Authors: Paula Meireles; Raquel Lucas; Ana Martins; Ana Cláudia Carvalho; Ricardo Fuertes; João Brito; Maria José Campos; Luís Mendão; Henrique Barros Journal: BMJ Open Date: 2015-05-12 Impact factor: 2.692
Authors: Nicolas Lorente; Marie Preau; Chantal Vernay-Vaisse; Marion Mora; Jerome Blanche; Joanne Otis; Alain Passeron; Jean-Marie Le Gall; Philippe Dhotte; Maria Patrizia Carrieri; Marie Suzan-Monti; Bruno Spire Journal: PLoS One Date: 2013-04-16 Impact factor: 3.240